PDUFA Date

PDUFA Date: ozekibart

Indication
patients with unresectable or metastatic conventional chondrosarcoma

Other upcoming events for INBX

Phase 3 ReadoutPhase 3 Topline: A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    PDUFA Date: ozekibart — INBX PDUFA Date | BioSniper